Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25 percent at one year and 50 percent at two years.1 GE Healthcare's Cardiology Solutions help you make decisions that matter for your patients, staff and hospital.

The Patient Journey

early detection
Due to the high mortality rates by the time patients are symptomatic, it is important to identify patients at risk, even when they are asymptomatic. Echocardiography can identify issues or abnormalities related to Aortic Valve structure and function.
Diagnosis is based in part on ECG interpretation of the heart rhythm and clinical history.3 Studies indicate that one of the key factors is to differentiate between chronic and paroxysmal AF in order to find the optimal management strategy for the patient.3
pre-procedure planning
For patients choosing a transcatheter replacement, non-invasive cardiovascular imaging, such as Ultrasound, CT, and MR are typically used to assess anatomy to plan the access site and size the valve.
During the transcatheter aortic valve replacement, steps are taken to ensure the most effective result, including valve sizing, position, and function are optimal.
patient follow-up
After the procedure, care is taken to ensure functionality of the valve typically using non-invasive imaging and ECG.
digital foundation and innovations
Digital solutions, analytics and AI innovations such as GE Healthcare's Edison Platform, Muse and Centricity Cardio Enterprise connect our wing-to-wing technologies to practitioners for better cardiology outcomes, more efficiently.
  • The latest in Cardiology